The intervention study of leucine enriched jelly on ADL improvement in the elderly requiring long-term care.

The intervention study of leucine enriched jelly on ADL improvement in the elderly requiring long-term care. - The intervention study of leucine enriched jelly on ADL improvement in the elderly requiring long-term care.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016232

Enrollment

Registered

2015-02-01

Start date

2015-02-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The elderly requiring long-term care

Interventions

Leucine enriched jelly Period of 12 weeks Daily dose 100 g Number-frequency once a day

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Geriatric health services facilities residents. Aged 65 years and older. Oral ingestion of universal design Food Category 4 or more is possible.

Exclusion criteria

Exclusion criteria: Unable to understand the explanation of study. Leucine enriched jelly intake denial cases. Apple allergy. Stage of chronic kidney disease G4, G5 without dialysis. Vitamin D intake in sum of diet and nutritional supplements is more than 4000IU. Inappropriate to participate judged by doctors.

Design outcomes

Primary

Measure	Time frame
FIM (Functional Independence Measure)	—

Secondary

Measure	Time frame
Nutrition and clinical test data, muscle mass and muscle strength.	—

Countries

Japan

Contacts

Public ContactYasuko Karibe

Nursing home Rihab-park Maioka Nutrition Division

Karibe-yasuko@shinzen.jp045-825-3388

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026